'We could be dead in 6 months': Chronic lung sufferers on future without life-saving drug
Patients who suffer from a chronic lung condition, Alpha 1, were told last Friday that they will lose access to a vital drug called Respreeza at the end of the month.
The HSE has said they were unable to reach an agreement with the pharmaceutical company that makes the life-changing drug, CSL Behring, meaning that some patients "could be dead in six months," according to campaigners.
